NCT05674162

Brief Summary

Observer reactivity, also known as the 'Hawthorne effect', can roughly be described as the alteration of behaviour as a consequence of observation or awareness of measurement. Although researchers are aware of a potential observation effect during measurements, observer reactivity may also influence assessments that are performed as part of clinical care. Previous research on observer reactivity during gait measurements has resulted in contradicting outcomes and most studies examined the effects of participation in research rather than the clinical measurement of gait in a gait lab setting or the observation by professionals. Therefore, the aim of this study is to examine the differences in gait pattern between unobserved walking, observed walking, and observed walking combined with awareness of measurement, in a within-subjects repeated measures design.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2022

Completed
11 days until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 6, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
Last Updated

December 13, 2023

Status Verified

December 1, 2022

Enrollment Period

4 months

First QC Date

December 21, 2022

Last Update Submit

December 6, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Gait velocity

    Mean walking speed (meters/second)

    5 minutes

Secondary Outcomes (8)

  • Stride length

    5 minutes

  • Cadance

    5 minutes

  • Stance time symmetry

    5 minutes

  • Swing time symmetry

    5 minutes

  • percent single leg stance

    5 minutes

  • +3 more secondary outcomes

Other Outcomes (1)

  • Fugl Meyer Assessment of Lower Extremities

    2 minutes

Study Arms (1)

Gait measurement

EXPERIMENTAL

Use of four accellerometers/sensors (1 on each foot, one on the lumbar area and one on the sternum) that measure gait parameters during walking.

Behavioral: UnobservedBehavioral: ObservedRadiation: Unobserved & Measured

Interventions

UnobservedBEHAVIORAL

Participants walk a distance of 40 meters wearing the sensors, unobserved by the researcher.

Gait measurement
ObservedBEHAVIORAL

Participants walk a distance of 40 meters wearing the sensors, observed by the researcher.

Gait measurement

Participants walk a distance of 40 meters wearing the sensors, unobserved by the researcher and aware of the gait measurement by the sensors.

Gait measurement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subacute or chronic stroke (\>3 months ago)

You may not qualify if:

  • Not able to walk 50 meters without resting.
  • Not able to understand instructions given by the researcher.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sint Maartenskliniek

Ubbergen, Gelderland, 6574 NA, Netherlands

Location

MeSH Terms

Conditions

Stroke

Interventions

No-Observed-Adverse-Effect Level

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Toxicity TestsInvestigative TechniquesToxicological PhenomenaPharmacological and Toxicological PhenomenaPhysiological Phenomena

Study Officials

  • Noël LW Keijsers, PhD

    Sint Maartenskliniek

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
The participants are masked to existence of different conditions, not to the measurement of their data.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Single group, repeated measures model.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 21, 2022

First Posted

January 6, 2023

Study Start

January 1, 2023

Primary Completion

May 1, 2023

Study Completion

May 1, 2023

Last Updated

December 13, 2023

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations